 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cagrilintide for Sale > Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10

Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - large image1

Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image1

Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image2

Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image3

Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10 buy - image4

Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10

Name: Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10
Brand: Maxshow
SKU: pr2504091214
Price: 2.2 USD
Availability: InStock

66 Inquiries

Unit Price: Get Latest Price 

CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ningbo

Brand:

Maxshow

Packaging:

5mg 10mg 15mg 30mg per vial; 10vials/box

Sample Available:

Yes

Price valid (until):

2025-05-09

Contact Supplier

 Chat Now

MaxShow Capital Limited

Company Type:

Trader

Location:

The British Virgin Islands

Payment Terms:

TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Average Lead Time:

7 days

Qualification:

Main Products:

peptides

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Detail

Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity.

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.

English name	Thymalin
Cas number	63958-90-7
Synonyms	pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn; STF, SeruM ThyMic Factor, ThyMulin; L-Asparagine,5-oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-; Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH trifluoroacetate salt; Serum thymic factor (porcine); Thymic serum factor; Thymic serum factor (pig); PYR-ALA-LYS-SER-GLN-GLY-GLY-SER-ASN
Purity	99%

Other hot selling products:

Semaglutide is a new generation GLP-1 (glucagon-like peptide-1) analogues. Semaglutide is a long-acting dosage form based on the basic structure of liraglutide, which is more effective in the treatment of type 2 diabetes mellitus. Compared with lilarlutide, somalutide has a longer aliphobic chain and an increased hydrophobicity, but somalutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced.PEG modification can not only tightly bind to albumin, cover up the DPP-4 enzymatic hydrolysis site, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Molecular Weight: 4813.45

Appearance: White Powder

Purity (HPLC): ≥99.0%

Single Impurity (HPLC): ≤1.0%

Moisture Content (Karl Fischer): ≤10.0%

Peptide Content: ≥80.0%

Storage: Store at -20℃ degrees Celsius in a dry and cool place.

Storage Condition: Store at -20°C Solubility in DMSO: 3mg/mL (0.73 mM)

SEMAGLUTIDE & TIRZEPATIDE

GLP-1 agonists were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called Semaglutide & Tirzepatide.
Tirzepatide is dosed at 5-15mg per week

Semaglutide is dosed at 0.5-2.4mg per week

Product Function:

Helps slow food leaving your stomach
Helps prevent your liver from making too much sugar
Helps the pancreas produce more insul when your blood sugar levels are high
Can help control blood glucose
Can reduce hyperglycemia, especially after meals
Can reduce fasting insul and fasting glucose
Can reduce hemoglobin A1c
Can decrease appetite and caloric intake, while inhibiting weight gain
Has been shown to lower triglyceride levels and oxidative stress from high LDL
Has been shown to help induce weight loss in obese patients with higher dosing
Helps decrease leptin and increase leptin sensitivity
Can increase the conversion of white fat to brown fat

Shop Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10-Detailed Image 1

Shop wholesale price TD from China CAS 5721-91-5-Detailed Image 2

Shop wholesale price TD from China CAS 5721-91-5-Detailed Image 4

Items	Specifications

ECHEMI Editorial Reference

Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

Basic Info

Product Name:

Cagrilintide

Other Name:

‌Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide

CAS No.:

1415456-99-3

Molecular Formula:

C194H312N54O59S2

Molecular Weight:

EC Number:

206-141-6

Color/Form:

White to off-white

Categories:

Bulk Drug Intermediates

Research

Class:

Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

Status:

Investigational — Phase 3 (REDEFINE program, CagriSema combination)

Mechanism:

A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.

Activity note:

Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

Source:

MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

Clinical Development:

NCT05249895; NCT05249882

References

PubChem:

PubChem

Literature:

MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation

Disclaimer:

Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

Seller Information

Business Type:
Trader

Main Products:
peptides

Location:
BRITISH VIRGIN ISLANDS

Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
7 days

Total Annual Revenue:
$2.5 million-$5 million

Total Employees:
11-50

Year of Establishment:
2024

Inquiry History

66 Inquiries

Country	Product	Purchase Quantity	Date Posted
United States	Cagrilintide	20 MG	Sep 30, 2026
Australia	Cagrilintide	20 MG	Aug 17, 2026
United Kingdom	Cagrilintide	10 MG	Jul 31, 2026
France	Cagrilintide	10 MG	May 22, 2026
Australia	Cagrilintide	4 MT	Mar 9, 2026
United States	Cagrilintide	15 MG	Feb 25, 2026
United States	Cagrilintide	10 PCS	Dec 27, 2025
United States	Cagrilintide	2 MT	Dec 21, 2025
United States	Cagrilintide	100 MG	Oct 28, 2025
United States	cagrilintide	2 MT	Aug 8, 2025
Philippines	Retatrutide	5 MG	Aug 5, 2025
China	Cagrilintide	100 G	May 6, 2025
United States	cagrilintide	5 MG	Feb 18, 2025
United States	Cagrilintide	3 MT	Feb 7, 2025
United States	Cagrilintide	100	Nov 12, 2024
United States	Cagrillintide Lyophilized powder	100 MG	Jul 4, 2024
United States	Cagrillintide Lyophilized powder	1000 MG	Apr 20, 2024
United States	Cagrilintide	10 MG	Sep 23, 2026
United States	Cagrilintide	25 MG	Aug 31, 2026
United States	Cagrlintide	1 MT	Jul 31, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
Cagrilintide Peptides 99% purity Weight Loss Peptide 10mg 15mg 30mg Fast Shipping	Pharmaceutical Grade/99	$2/G FOB	Yingtai Technology Co., Ltd	Inquiry
99% purity Cagrilintide Peptides Weight Loss Peptide 10mg Fast Shipping	Pharmaceutical Grade/99	$170-200/UNIT FOB	changxiaokeji	Inquiry
Cagrilintide CAS 1415456-99-3 99% Purity Lyophilized Powder Weight Loss PeptideBulk Stock Cagrilintide 99% Purity Pharmaceutical Intermediate	Pharmaceutical Grade/99	$20-22/MT FOB	LingMi BioTechnology Co., Ltd	Inquiry
CGL10 CGL10 High-quality peptides,white powder//provide home deliveryservice-available in stock in the warehouse99% purity + perfect after-sales servi	Research Grade/99	$30-35/UNIT FOB	Yiwu Nianwu	Inquiry
Wholesale 99%+ purity weight loss peptide Cagrilintide bulk raw CAS 1415456-99-3	Pharmaceutical Grade/99	$1/G FOB	Hubei Meisang Trading Co.,Ltd	Inquiry

Max show Peptide Powder Cagrilintide Lyophilized Powder 10 mg Cagrilintide vials in kits of 10

Product Description

Seller Information

Inquiry History

SEMAGLUTIDE & TIRZEPATIDE

More Choices Find All Products for Sale 

Related Searches

More from this Seller